Evidence map›Paper›PMID 42592811›Full record

ArticlePharmacoepidemiology and drug safety2026

ICD-10-CM-Based Algorithms to Identify Bacteremia Incorporating Pathogen-Specific Codes: A Validation Study.

Madison G Ponder, Alan C Kinlaw, Elizabeth S Dodds Ashley, Jennifer L Lund, Emily J Ciccone, Michele Jonsson Funk

Abstract readValidation Study
In one paragraph

Article in Pharmacoepidemiology and drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Madison G PonderDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-4933-7216
Alan C KinlawDivision of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-4279-8685
Elizabeth S Dodds AshleyDuke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, USA.
Jennifer L LundDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-1108-0689
Emily J CicconeDivision of Infectious Diseases, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0003-2445-8473
Michele Jonsson FunkDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0002-3756-7540

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

purposeStudying patients with bacteremia in real-world data often requires using microbiologic data to confirm bacterial growth and species. When microbiologic data are unavailable, pathogen-specific diagnostic codes may be used to classify the bacteremia type. We developed and validated ICD-10-CM-based algorithms for identifying any bacteremia, Gram-negative bacteremia, and Enterobacteriaceae bacteremia.

methodsWe identified patients ≥ 18 years with a hospitalization ≥ 2 days to any Duke Antimicrobial Stewardship Outreach Network hospital from January 1, 2021 to May 31, 2024. Blood culture results were the reference standard for classifying true cases of bacteremia. We evaluated 15 candidate algorithms developed based on previously published algorithms, in addition to the bacteremia ICD-10-CM code (R78.81) and pathogen-specific ICD-10-CM codes. We estimated sensitivity, specificity, positive predictive value (PPV), and negative predictive value with 95% confidence intervals using generalized estimating equations to account for correlated hospitalizations.

resultsAmong 907 958 hospital admissions (623 556 patients), algorithms with bacteremia and pathogen-specific codes had high specificity (range: 97.3%-100.0%) and low sensitivity (range: 4.9%-58.1%). Algorithms with bacteremia codes and no pathogen codes were more sensitive (range: 67.4%-68.6%) and less specific (range: 91.1%-91.2%). In subgroup analyses, PPV for any bacteremia was highest among patients alive at discharge, age ≥ 65, and discharged on antibiotics with Gram-negative coverage (68.9% [65.1%-72.7%]).

conclusionsWe developed and internally validated algorithms to identify bacteremia, Gram-negative bacteremia, and Enterobacteriaceae bacteremia in adult patients. Studies seeking to maximize specificity could consider algorithms that include bacteremia and pathogen-specific codes, whereas studies seeking to maximize sensitivity could consider algorithms only requiring a bacteremia code.

Indexed as

AlgorithmsBacteremiaEnterobacteriaceae InfectionsGram-Negative Bacterial InfectionsInternational Classification of DiseasesAgedAnti-Bacterial AgentsEnterobacteriaceaeFemaleGram-Negative BacteriaHospitalizationHumansMiddle AgedPredictive Value of TestsSensitivity and SpecificityAnti-Bacterial Agentsalgorithmbacteremiamicrobiologic datasepsisvalidation

Identifiers

PMID42592811
PMCPMC13470842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.